Status: Recruiting
Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery
This is a Phase II study of neoadjuvant therapy of AK104 combined with nab-paclitaxel/carboplatin in fertility saving surgery for stage IB2-IB3 cervical cancer (FIGO 2018). The main questions it aims to answer are: * · Evaluate the safety of AK104 combined with nab-paclitaxel/carboplatin in the neoadjuvant treatment of cervical cancer * · Evaluate the tumor regression and Major Pathological Response(MPR) of AK104 combined with nab-paclitaxel/carboplatin as neoadjuvant therapy for cervical cancer.
Participants needed: 30
Trial details
Phase: Phase 2Age: 18-45Biological sex: FemaleType: InterventionalSponsor: Xiaohua WuUpdated: Jan 17, 2024Locations: 1
Eligibility criteria
Voluntarily sign a written ICF. [+12]
The histopathological types are small cell carcinoma, gastric adenocarcinoma, et... [+21]